I have been living with Type 1 Diabetes for 20 years now. This disease challenges me in multiple ways each day and although I try to live as much of a "normal" lifestyle as possible, I still have to face its difficulties 24/7. Luckily, I found something that has brought a new light to this large part of my life. For the past two years, I have had the honor to run the Boston Marathon for the Juvenile Diabetes Research Foundation (JDRF). This event has not only allowed me to be more open regarding the challenges of diabetes, it has also given me a unique platform to connect with other Type 1 Diabetics and raise awareness for the disease. Whether it is a young Type 1 Diabetic who wants to take control of this disease, or someone who simply needs every day support -- the Marathon has allowed people like myself to connect and support one another.
With only a small team representing JDRF, I am honored to have the chance to continue to fundraise and take one step closer to making Type 1, Type None. Your support last year played a large part towards our fundraising goal as a team, and I want to continue to use the marathon as a platform to raise awareness and funds to benefit the lives of all Type 1 Diabetics. None of this would have been possible without your support and donations in previous years.
Whether it is a donation or simply sharing this fundraiser page, any support is greatly appreciated. If you would like to make a donation to JDRF and all Type 1 Diabetics, please consider visiting the link below. Thank you!
____________________________________________________________________________________
JDRF New England Chapter wrote:
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.
JDRF works every day to change the reality of this disease for millions of people—and to prevent anyone else from ever knowing it—by funding research, advocating for government support of research and new therapies, ensuring new therapies come to market and connecting and engaging the T1D community.
